[1]王晓亮,赵光宇.过敏性紫癜患儿血清基质金属蛋白酶-13、白细胞介素-9和肿瘤坏死因子-α表达水平变化及意义[J].陕西医学杂志,2022,51(1):92-95.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.024]
　WANG Xiaoliang,ZHAO Guangyu.Changes and significance of serum MMP-13,IL-9 and TNF-α levelsin children with Henoch-Schonlein purpura[J].,2022,51(1):92-95.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.024]
点击复制

过敏性紫癜患儿血清基质金属蛋白酶-13、白细胞介素-9和肿瘤坏死因子-α表达水平变化及意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年1期
页码:
92-95
栏目:
临床检验
出版日期:
2022-01-05

文章信息/Info

Title:
Changes and significance of serum MMP-13,IL-9 and TNF-α levelsin children with Henoch-Schonlein purpura
作者:
王晓亮1; 赵光宇2
(1.榆林市第一医院检验科,陕西 榆林 719000; 2.西安市中心医院儿科,陕西 西安 710004)
Author(s):
WANG Xiaoliang; ZHAO Guangyu
(Department of Laboratory Medicine,the First Hospital of Yulin,Yulin 719000,China)
关键词:
过敏性紫癜;  基质金属蛋白酶-13;  白细胞介素-9;  肿瘤坏死因子-α;  相关性;  影响因素
Keywords:
Henoch-Schonlein purpura;  Matrix metalloproteinase-13;  Interleukin-9;  Tumor necrosis factor-α;  Correlation;  Influencing factor
分类号:
R 554.6
DOI:
DOI:10.3969/j.issn.1000-7377.2022.01.024
文献标志码:
A
摘要:
目的:探讨过敏性紫癜(HSP)患儿血清基质金属蛋白酶-13(MMP-13)、白细胞介素-9(IL-9)和肿瘤坏死因子-α(TNF-α)表达水平变化及临床意义。方法:选取HSP患儿96例为HSP组,选择同期进行健康体检的儿童96例为对照组。检测两组血清MMP-13、IL-9和TNF-α表达水平。给予HSP患儿药物综合治疗后,比较不同疗效患儿血清MMP-13、IL-9和TNF-α表达水平。采用Spearsman法分析HSP患儿预后与上述指标水平的相关性。采用Logistic回归模型分析影响HSP患儿预后的因素。结果:HSP组血清MMP-13、IL-9和TNF-α表达水平高于对照组(均P<0.05)。在HSP组中,治疗后痊愈54例,显效36例,无效6例,有效率为93.75%。有效患儿血清MMP-13、IL-9和TNF-α表达水平低于无效患儿(均P<0.05)。Spearsman相关性分析显示,HSP患儿预后与血清MMP-13、IL-9和TNF-α表达水平呈正相关(r=0.722、0.542、0.443,均P<0.05)。Logistic回归分析显示,血清MMP-13、IL-9和TNF-α表达水平均为患儿预后的影响因素(均P<0.05)。结论:HSP患儿血清MMP-13、IL-9和TNF-α呈现高表达状况,与患儿预后存在相关性,也是影响患儿预后的重要因素。
Abstract:
Objective:To investigate the changes and significance of serum levels of matrix metalloproteases-13(MMP-13),interleukin-9(IL-9)and tumor necrosis factor-α(TNF-α)in children with Henoch-Schonlein purpura(HSP).Methods:Ninety-six children with HSP were selected as the HSP group,and 96 children who underwent physical examination during the same period were selected as the control group.The expression levels of serum MMP-13,IL-9 and TNF-α were detected in the two groups.After administering comprehensive drug treatment for children with HSP,the expression levels of serum MMP-13,IL-9 and TNF-α in children with different curative effects were compared.Spearsman method was used to analyze the correlation between the prognosis of children with HSP and the levels of the above indicators.Logistic regression model was used to analyze the factors affecting the prognosis of children with HSP.Results:The expression levels of serum MMP-13,IL-9 and TNF-α in the HSP group were higher than those in the control group(all P<0.05).In the HSP group,after treatment,54 cases were cured,36 cases were markedly effective,and 6 cases were ineffective,and the effective rate was 93.75%.The expression levels of serum MMP-13,IL-9 and TNF-α in effective children were lower than those in ineffective children(all P<0.05).Spearsman correlation analysis showed that the prognosis of children with HSP was positively correlated with serum MMP-13,IL-9 and TNF-α expression levels(r=0.722,0.542,0.443,all P<0.05).Logistic regression analysis showed that the expression levels of serum MMP-13,IL-9 and TNF-α were all influencing factors for the prognosis of children(all P<0.05).Conclusion:The serum levels of MMP-13,IL-9 and TNF-α are highly expressed in children with HSP,which are related to the prognosis of the children and are also important factors affecting the prognosis of the children.

参考文献/References:

[1] 陈治峰,王 丽,杜 娟,等.益气化斑方治疗过敏性紫癜疗效及对患儿Gd-IgA1、NF-κB水平的影响[J].陕西中医,2019,40(2):237-240.
[2] 沈克彦.紫仙丹对过敏性紫癜患儿β2微球蛋白、尿微量白蛋白的影响[J].陕西中医,2020,41(10):1382-1384.
[3] 张 燕,刘伟华.肺炎支原体感染与儿童过敏性紫癜关系探讨[J].陕西医学杂志,2021,50(2):170-172,176.
[4] 高 敏,丁 樱,任献青,等.河南省14809例儿童过敏性紫癜中医证型与发病规律回顾性分析[J].中医杂志,2021,62(9):772-776.
[5] Arnold KA,Gao J,Stein SL.A review of cutaneous hypersensitivity reactions in infants:From common to concerning[J].Pediatr Dermatol,2019,36(3):274-282.
[6] Aypar E,Demirta D,Aykan HH,et al.A girl with Henoch Schönlein purpura associated with acute rheumatic fever and review of literature[J].Turk J Pediatr,2018,60(5):576-580.
[7] 赵 茜,赵肖庆,刁立诚,等.伴皮肤紫癜的原发性干燥综合征患者的临床特征分析[J].诊断学理论与实践,2021,20(2):155-160.
[8] Crayne CB,Eloseily E,Mannion ML,et al.Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura:8 cases and a review of the literature[J].Pediatr Rheumatol Online J,2018,16(1):71-78.
[9] 周 彬,党小宁,傅忠国,等.紫癜性肾炎患儿血清PTX3、IgA/C3水平变化及与肾功能损伤的相关性[J].武警医学,2021,32(3):193-196.
[10] Di-Pietro GM,Castellazzi ML,Mastrangelo A,et al.Henoch-Schönlein purpura in children:Not only kidney but also lung[J].Pediatr Rheumatol Online J,2019,17(1):75-82.
[11] 蔡 浩,王 强,赵风云.过敏性紫癜患儿血浆C3、C4、IgA水平变化及其与肾脏损伤的关系[J].山东医药,2021,61(14):82-84.
[12] Duan H,Hua Y,Zhou K,et al.A delayed diagnosis of late-onset pulmonary hemorrhage in a toddler with Henoch-Schönlein purpura after regression of skin rash:A case report and literature review[J].BMC Pediatr,2020,99(44):e23025.
[13] 屈凤祥,常 红,林 毅,等.IL-1β基因多态性与儿童紫癜性肾炎易感性的相关性分析[J].中国临床医学,2021,28(2):273-277.
[14] Echavarría-García AC,Pozos-Guillén A,Tejeda-Nava F,et al.Oral management of children with Henoch-Schönlein purpura and associated glomerulonephritis:A scoping review[J].Eur J Paediatr Dent,2018,19(2):134-138.
[15] Jelusic M,Sestan M,Cimaz R,et al.Different histological classifications for Henoch-Schönlein purpura nephritis:Which one should be used?[J].Pediatr Rheumatol Online J,2019,17(1):10-18.
[16] 钱 宇,李秋平,高 凤,等.儿童过敏性紫癜合并肺炎支原体感染患儿外周静脉血Th17/Treg平衡性的检测及临床意义[J].中国小儿急救医学,2021,28(5):401-404.
[17] Li J,Wang XZ,Wang RC,et al.Pulmonary tuberculosis presenting as Henoch-Schönlein purpura:Case report and literature review[J].Medicine(Baltimore),2020,99(40):e22583.
[18] López-Mejias R,Castaneda S,Genre F,et al.Genetics of immunoglobulin-a vasculitis(Henoch-Schönlein purpura):An updated review[J].Autoimmun Rev,2018,17(3):301-315.
[19] 赵 晨,赵 萍,白 燕,等.过敏性紫癜儿童血清特异性免疫球蛋白E和免疫球蛋白G检测分析[J].中国医刊,2021,56(2):212-215.
[20] Oni L,Sampath S.Childhood IgA vasculitis(Henoch-Schonlein purpura)advances and knowledge gaps[J].Front Pediatr,2019,7(12):257-265.
[21] 黄 奔,范 维,王 萍,等.肿瘤坏死因子α在恶性肿瘤诊疗中的研究进展[J].分子诊断与治疗杂志,2021,85(9):1377-1380.

相似文献/References:

[1]于 铭,李 静,全守东,等.过敏性紫癜患儿不同时期血清促炎细胞因子水平变化及检测价值[J].陕西医学杂志,2021,50(9):1106.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.016]
　YU Ming,LI Jing,QUAN Shoudong,et al.Changes of serum pro-inflammatory cytokine levels in children with Henoch-Schonlein purpura in different periods and its detection value[J].,2021,50(1):1106.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.016]
[2]李 根,马 翠.过敏性紫癜患儿外周血微小RNA-155、Toll样受体2、Toll样受体4、氧化应激指标表达水平与Th17/Treg平衡的关系[J].陕西医学杂志,2023,52(3):301.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.012]
　LI Gen,MA Cui.Relationship between expression levels of miR-155,TLR2,TLR4,oxidative stress and Th17/Treg balance in peripheral blood of children with anaphylactoid purpura[J].,2023,52(1):301.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.012]
[3]刘丽莹,朱 影,毛国顺,等.过敏性紫癜患儿预后影响因素及其预测价值研究[J].陕西医学杂志,2024,(3):382.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.020]
　LIU Liying,ZHU Ying,MAO Guoshun,et al.Prognostic influencing factors and their predictive value of children with Henoch-Schnlein purpura[J].,2024,(1):382.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.020]
[4]王爱琳,潘 靓,张金秀,等.可溶性血管细胞黏附分子-1、中性粒细胞与淋巴细胞比值在过敏性紫癜患儿血清中的变化及检测意义[J].陕西医学杂志,2024,(8):1073.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.014]
　WANG Ailin,PAN Liang,ZHANG Jinxiu,et al.Changes of soluble vascular cell adhesion molecule-1 and neutrophil-to-lymphocyte ratio in the serum of children with Henoch-Schnlein purpura and their significance[J].,2024,(1):1073.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.014]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2017SF-098)
更新日期/Last Update: 2022-01-09